Ovarian Cancer | St. Stamford Modern Cancer Hospital Guangzhou

Ovarian Cancer

What is ovarian cancer?

Ovarian cancer is a kind of malignant tumor of the ovary, which refers to malignant tumors growing on the ovary, of which 90%~95% are primary cancers of the ovary, and the other 5%~10% are primary cancers of other parts metastasized to the ovary. Due to the lack of symptoms in the early stage of ovarian cancer, and even if there are symptoms, they are not specific, and the role of screening is limited, therefore, early diagnosis is difficult, and 60% to 70% of the cases are already in the advanced stage by the time of diagnosis, and the therapeutic effect of the advanced cases is not good.

Therefore, although the incidence rate of ovarian cancer is lower than that of cervical cancer and endometrial cancer, it ranks third among gynecological malignant tumors, but the mortality rate exceeds the sum of cervical cancer and endometrial cancer, ranking first among gynecological cancers, and it is the biggest disease that seriously threatens women’s health. The world cancer report shows that in 2020, the incidence rate of ovarian cancer will be 310,000 and the mortality rate will be 210,000.

So can middle and late-stage ovarian cancer be cured? Minimally invasive techniques with little side effects and trauma can help bladder cancer patients avoid surgical removal, avoid suffering from traditional radiotherapy, and effectively prolong survival.

For more knowledge about cancer, please click online doctors for consultation.

Ovarian Cancer Traditional Treatment Methods

Surgical treatmentSurgery to remove cancerous tissue and clean cervical lymph nodes that may have metastasis.
Radiation TherapyRadiation therapy for follicular adenocarcinoma.
chemotherapyOften used as palliative therapy for inoperable or distantly metastatic advanced cancer.
Chinese treatmentTraditional Chinese medicine therapy can inhibit the development of cancer, improve the immune function of patients with thyroid cancer, and reduce the toxic and side effects of radiotherapy and chemotherapy.

Ovarian Cancer Treatment Technology

https://www.moderncancerhospitalmy.com/treatment-technologies/2023/0728/7021.html

Combined Knife

Combined Knife, it’s not actual surgical knife, but a composite cryogenic freezing surgical system, which conduct cold and heat a

https://www.moderncancerhospitalmy.com/treatment-technologies/2023/0728/7019.html

Interventional Therapy

Interventional therapy is a mini-invasive therapy performed under the guidance of medical imaging equipments. With a 1-2 millimeter

https://www.moderncancerhospitalmy.com/treatment-technologies/2023/0818/7346.html

Nanoknife Technology

Nanoknife is a brand-new cutting-edge ablation technology for tumor treatment. It breaks the membrane of tumor cells with high volt

https://www.moderncancerhospitalmy.com/treatment-technologies/2023/0818/7311.html

Particle Knife

Particle knife (also called 125I Seed Implants) is applied to a variety of primary and metastatic tumors nowadays. 125I seeds are s

https://www.moderncancerhospitalmy.com/treatment-technologies/2023/0728/7020.html

Cryotherapy

Cryotherapy, also named cryosurgery therapy or cryoablation, is a medical technique both ancient and modern.

https://www.moderncancerhospitalmy.com/treatment-technologies/2023/0818/7349.html

DEB-TACE

Drug-eluting bead transcatheter arterial chemoembolization

Drug-eluting beads transcatheter arterial chemoembolization (DEB-TACE) is an interventional therapy used in tumor treatment. It is

https://www.moderncancerhospitalmy.com/treatment-technologies/2023/0818/7327.html

Radiofrequency Ablation

Radiofrequency ablation, sometimes referred to as RFA, is a minimally invasive treatment for cancer. It is an image-guided techniqu

Ovarian Cancer Patients' Story

They come from different countries around the world, but they have experienced the same experience and endured the pain that cancer has brought to them. However, now, with the effective treatment and meticulous care of St. Stamford Modern Cancer Hospital Guangzhou, they have rekindled their confidence in life and become anti-cancer fighters. Here, they share their anti-cancer experience, love and warmth with everyone.

Lung cancer: Ms. Manussawan; ThailandSurvive for more than 3 years

Lung Cancer: JAFFAR ABDUL MANAN; IndonesiaMore than 5 years

Liver cancer: Mr. Xie; MalaysiaSurvive for more than 5 years

lung cancer: Mr. Sun; ChinaSurvive for more than 2 years

spindle cell sarcoma: Ms. Li; ChinaSurvive for more than 5 years

Colorectal cancer: Nurdin; IndonesiaSurvive for more than 6 years

stomach cancer: BASTARI; IndonesiaSurvive for more than 8 years

breast cancer: Ms. Chen; MalaysiaSurvive for more than 9 years

Breast Cancer: SAIDAH; IndonesiaSurvive for more than 5 years

Gallbladder Cancer: ONG LEE SING; MalaysiaSurvive for more than 5 years

Liver Cancer: VO VAN HOA; VietnamSurvive for more than 4 years

non-Hodgkin's lymphoma: HENKY TJANDRA; IndonesiaSurvive for more than 4 years

Breast Cancer: THE CARINA THERESIA; IndonesiaSurvive for more than 16 years

Ovarian Cancer: ERLINDA FRANCISCO; PhilippinesSurvive for more than 5 years

Esophageal Cancer: DAM VAN HOE; VietnamSurvive for more than 5 years

Lymphoma: MICHAEL SANJAYA IRAWAN; IndonesiaSurvive for more than 5 years

Endometrial Cancer: YATI; IndonesiaSurvive for more than 5 years

Lung Cancer: Nguyen Van Chuyen; VietnamSurvive for more than 5 years

thymus cancer: TARUMA TRIBUDIMAN; IndonesiaSurvive for more than 5 years

Lung Cancer: Thi Hue Nguyen; VietnamSurvive for more than 5 years

MDT TEAM

: Song Shijun; Chief Expert of Oncology Department | Chief physician

: Liu Yuansheng; Minimally Invasive Dean, Integrative Medicine Chief Expert | Deputy Chief Physician

: Peng Xiaochi; Director of Oncology Department | Chief Physician

: Dai Wenyan; Director of Oncology Department of Oncology, Director of Breast Cancer Center | Associate Chief Physician

: Ma Xiaoying; Director of Oncology Department | Associate Chief Physician

: Lin Jing; Deputy Director, International Oncology Ward | Attending Physician

: Wu Qingkai; Chief doctor | Attending Doctor

: Zhen Yanli; Director of Radiology Department | Associate Chief Physician

: Zhao Yifan; Oncology Resident | Physician-in-Charge

: Qin Yubing; Attending physician ,Oncology Department | Attending physician

Form

Patient's Name *

Cancer type *

Phone number *

Medical reports*

Yes No

Ovarian Cancer Staging

Ovarian Cancer Stages and Corresponding 5-year Survival Rate

Ovarian Cancer Stage I: 85%-90%;

Ovarian Cancer Stage II: 70%-73%;

Ovarian Cancer Stage III: 39%;

Ovarian Cancer Stage IV: 17%.

The staging of ovarian cancer is of great significance to the treatment plan and treatment effect. The extent, size and metastasis of the tumor affect the doctor's choice of treatment plan. The age, menopause and overall health status of the woman may have an impact on treatment options and prognosis.

For more knowledge about cancer, please click online doctors for consultation.